| Sep 6 |
TC BioPharm Intends to Launch Preclinical Studies for Treatment of Monkey Pox
|
| Sep 5 |
TCBP Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Sep 3 |
Sector Update: Health Care Stocks Decline Late Afternoon
|
| Sep 3 |
TC BioPharm stock rallies 20% on Phase 2 study update
|
| Sep 3 |
TCBP Announces Dosing of 5 New Patients in ACHIEVE
|
| Aug 29 |
TC BioPharm secures European patent for cancer treatment
|
| Aug 28 |
TC BioPharm Announces Closing of Upsized $6.0 Million Public Offering
|
| Aug 28 |
TC BioPharm Announces Grant of European Patent Covering Use of Modified Gamma Delta Cells for the Treatment of Cancer and Viral Indications
|
| Aug 16 |
TC Biopharm files to sell 1.5M American depositary shares, warrants
|
| Aug 15 |
TC BioPharm regains compliance with Nasdaq
|
